Enter assignee name

% Expired Patents = 25.0

Forward Citations = 19

Loading Chart...

6 inventors (with patents filed for the assignee):

Nicholas D Smith (8 out of 59 patents)

Steven P Govek (7 out of 34 patents)

Johnny Yasuo Nagasawa (6 out of 27 patents)

4. Karensa L Douglas (2 out of 6 patents)

5. Andiliy Gokching Lai (2 out of 19 patents)

6. Stephen P Govek (1 out of 1 patent)

8 patents: Sort by Forward Citations

1. 11236071 - Farnesoid X receptor agonists and uses thereof (2022-02-01),

2. 11214538 - Farnesoid X receptor agonists and uses thereof (2022-01-04),

3. 11084817 - Farnesoid X receptor agonists and uses thereof (2021-08-10),

4. 10961198 - Farnesoid X receptor agonists and uses thereof (2021-03-30),

5. 10927082 - Farnesoid X receptor agonists and uses thereof (2021-02-23),

6. 10703712 - Farnesoid X receptor agonists and uses thereof (2020-07-07),

7. 10626081 - Farnesoid X receptor agonists and uses thereof (2020-04-21),

8. 10377717 - Farnesoid X receptor agonists and uses thereof (2019-08-13),

Metacrine is a biotechnology company focused on discovering and developing innovative therapies for metabolic diseases. The company's proprietary drug discovery platform enables the identification of novel drug targets and the development of small molecule drugs to address unmet medical needs in metabolic diseases such as NASH and diabetes. Metacrine is committed to bringing new treatment options to patients with metabolic diseases.

Profile summary based on public USPTO records.